A multi-center study on the effectiveness of the Daytime-Nighttime Appliance for OSA treatment
VJNeurology
A multi-center study on the effectiveness of the Daytime-Nighttime Appliance for OSA treatment
2:01
Recommendations for neurologists treating patients with RLS
VJNeurology
Recommendations for neurologists treating patients with RLS
1:56
Mitigating the risk of iron overload in patients with RLS treated with iron supplementation
VJNeurology
Mitigating the risk of iron overload in patients with RLS treated with iron supplementation
2:03
The relationship between RLS and cognitive impairment
VJNeurology
The relationship between RLS and cognitive impairment
1:01
The current approaches to managing pediatric sleep disturbances
VJNeurology
The current approaches to managing pediatric sleep disturbances
1:35
Current limitations in pediatric sleep research and treatment
VJNeurology
Current limitations in pediatric sleep research and treatment
6:45
The impact of a changing society on pediatric sleep
VJNeurology
The impact of a changing society on pediatric sleep
7:07
Current perspectives on the management of CSA
VJNeurology
Current perspectives on the management of CSA
2:34
Implementing applications of circadian health in public institutions and society
VJNeurology
Implementing applications of circadian health in public institutions and society
1:48
Advancing the understanding of narcolepsy pathology to improve patient quality of life
VJNeurology
Advancing the understanding of narcolepsy pathology to improve patient quality of life
1:47
Recommendations of the European guidelines on the accreditation of sleep medicine centers
VJNeurology
Recommendations of the European guidelines on the accreditation of sleep medicine centers
2:04
Overlapping feature of disturbed sleep across several neurological disorders
VJNeurology
Overlapping feature of disturbed sleep across several neurological disorders
2:13
The role ultra-long-term EEG data may play in understanding the interplay of epilepsy and sleep
VJNeurology
The role ultra-long-term EEG data may play in understanding the interplay of epilepsy and sleep
1:19
The importance of early surgery in pediatric epilepsies
VJNeurology
The importance of early surgery in pediatric epilepsies
1:20
The need for technological solutions for objective long-term monitoring of epileptic seizures
VJNeurology
The need for technological solutions for objective long-term monitoring of epileptic seizures
1:51
Highlights in the field of epilepsy surgery from EEC 2024
VJNeurology
Highlights in the field of epilepsy surgery from EEC 2024
1:01
Challenges in validating a clinical prediction model of seizure risk in patients with epilepsy
VJNeurology
Challenges in validating a clinical prediction model of seizure risk in patients with epilepsy
2:47
Focal cortical stimulation with the EASEE system for pharmacoresistant focal epilepsy
VJNeurology
Focal cortical stimulation with the EASEE system for pharmacoresistant focal epilepsy
7:51
VNS versus DBS for drug-resistant epilepsy
VJNeurology
VNS versus DBS for drug-resistant epilepsy
3:44
The need for a seizure prediction tool to optimize epilepsy treatment
VJNeurology
The need for a seizure prediction tool to optimize epilepsy treatment
1:35
Enhancing the use of advanced MRI in MS diagnosis and monitoring
VJNeurology
Enhancing the use of advanced MRI in MS diagnosis and monitoring
1:24
Promoting sustainability in healthcare & considering the environmental impact of congress travel
VJNeurology
Promoting sustainability in healthcare & considering the environmental impact of congress travel
1:33
What should be done in pregnancy for pts with myasthenia gravis & unanswered questions that remain
VJNeurology
What should be done in pregnancy for pts with myasthenia gravis & unanswered questions that remain
1:22
Novel agents being explored for the treatment of CIDP
VJNeurology
Novel agents being explored for the treatment of CIDP
2:22
Investigating CAR T-cell therapy in the treatment of MS
VJNeurology
Investigating CAR T-cell therapy in the treatment of MS
2:14
Improving the assessment of patients with MG: monitoring QoL & psychiatric comorbidities
VJNeurology
Improving the assessment of patients with MG: monitoring QoL & psychiatric comorbidities
2:35
Results of a Phase IIa trial investigating rozanolixizumab for CIDP
VJNeurology
Results of a Phase IIa trial investigating rozanolixizumab for CIDP
1:30
Initiatives and activities of the RRFS
VJNeurology
Initiatives and activities of the RRFS
2:51
Trials investigating the complement inhibitor riliprubart for treating CIDP
VJNeurology
Trials investigating the complement inhibitor riliprubart for treating CIDP
4:22
An umbrella review of early mobilization decision after acute stroke
VJNeurology
An umbrella review of early mobilization decision after acute stroke
2:00
Impact of sleep disturbances on neuropsychiatric symptoms in AD
VJNeurology
Impact of sleep disturbances on neuropsychiatric symptoms in AD
2:02
Using digital tools in rare brain disorders: benefits, drawbacks, & patient perspectives
VJNeurology
Using digital tools in rare brain disorders: benefits, drawbacks, & patient perspectives
11:09
Developing a training course for HCPs who use brain stimulation techniques
VJNeurology
Developing a training course for HCPs who use brain stimulation techniques
1:49
Developing the SynNeurGe criteria for use in Parkinson's research
VJNeurology
Developing the SynNeurGe criteria for use in Parkinson's research
5:31
The mechanisms behind orthostatic hypotension in pure autonomic failure
VJNeurology
The mechanisms behind orthostatic hypotension in pure autonomic failure
1:44
The potential of circular RNAs as novel biomarkers in Parkinson's disease
VJNeurology
The potential of circular RNAs as novel biomarkers in Parkinson's disease
2:27
The importance of early intervention and long-term treatment in patients with epilepsy
VJNeurology
The importance of early intervention and long-term treatment in patients with epilepsy
1:23
The challenges with implementing transcranial electrical brain stimulation into clinical practice
VJNeurology
The challenges with implementing transcranial electrical brain stimulation into clinical practice
2:31
Predicting clinical outcomes of patients with Parkinson's who received deep brain stimulation
VJNeurology
Predicting clinical outcomes of patients with Parkinson's who received deep brain stimulation
1:45
The new Sleep Environmental Factors (SEF) measure for assessing factors influencing sleep hygiene
VJNeurology
The new Sleep Environmental Factors (SEF) measure for assessing factors influencing sleep hygiene
7:19
The latest developments in the treatment of RLS
VJNeurology
The latest developments in the treatment of RLS
2:19
Using an under-mattress monitoring device to study the prevalence of sleep apnea
VJNeurology
Using an under-mattress monitoring device to study the prevalence of sleep apnea
2:33
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
VJNeurology
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
1:39
The effects of a comprehensive rehabilitation program for patients with narcolepsy
VJNeurology
The effects of a comprehensive rehabilitation program for patients with narcolepsy
3:38
Types of consumer sleep monitoring devices and their role in improving the diagnosis of sleep apnea
VJNeurology
Types of consumer sleep monitoring devices and their role in improving the diagnosis of sleep apnea
1:35
Incorporating new developments in RLS into clinical guidelines
VJNeurology
Incorporating new developments in RLS into clinical guidelines
2:08
The need for further studies investigating the benefit of chronomedicine
VJNeurology
The need for further studies investigating the benefit of chronomedicine
1:24
A study investigating imagery rescripting as a technique to treat insomnia
VJNeurology
A study investigating imagery rescripting as a technique to treat insomnia
3:45
Gender-specific patterns of sleep in children and the potential role in psychiatric disorders
VJNeurology
Gender-specific patterns of sleep in children and the potential role in psychiatric disorders
5:16
The implementation of the new MS diagnostic criteria into clinical practice
VJNeurology
The implementation of the new MS diagnostic criteria into clinical practice
2:57
Improving the global applicability of the new MS diagnostic criteria
VJNeurology
Improving the global applicability of the new MS diagnostic criteria
1:49
How a better understanding of RAW and PIRA may improve outcomes & therapeutic interventions in MS
VJNeurology
How a better understanding of RAW and PIRA may improve outcomes & therapeutic interventions in MS
1:54
Investigating evobrutinib and other BTK inhibitors for the treatment of MS
VJNeurology
Investigating evobrutinib and other BTK inhibitors for the treatment of MS
3:05
The evolving understanding of the disease course in MS
VJNeurology
The evolving understanding of the disease course in MS
1:49
The importance of a multi-disciplinary team in MS lifestyle management
VJNeurology
The importance of a multi-disciplinary team in MS lifestyle management
1:42
Disability accrual in MS: RAW versus PIRA
VJNeurology
Disability accrual in MS: RAW versus PIRA
1:58
The clinical significance of a prodromal phase in MS
VJNeurology
The clinical significance of a prodromal phase in MS
3:35
Lower cognitive performance before MS symptom onset: a Norweigan study
VJNeurology
Lower cognitive performance before MS symptom onset: a Norweigan study
1:57
The concept of an MS prodomal phase and how it has long been neglected
VJNeurology
The concept of an MS prodomal phase and how it has long been neglected
1:29
The impact of dietary patterns on MS: what remains unknown
VJNeurology
The impact of dietary patterns on MS: what remains unknown
2:07
Barriers to the treatment of MS in the MENA region
VJNeurology
Barriers to the treatment of MS in the MENA region
2:55
Adverse events associated with natalizumab in MS and advice on mitigating them
VJNeurology
Adverse events associated with natalizumab in MS and advice on mitigating them
1:17
Natalizumab versus anti-CD20 monoclonal antibodies in the treatment of MS
VJNeurology
Natalizumab versus anti-CD20 monoclonal antibodies in the treatment of MS
1:50
Updates to the McDonald criteria for the diagnosis of MS
VJNeurology
Updates to the McDonald criteria for the diagnosis of MS
2:38
The challenge of defining progression independent from relapse activity in MS
VJNeurology
The challenge of defining progression independent from relapse activity in MS
4:19
Comparing the prodromal phase in MS to other immune-mediated diseases
VJNeurology
Comparing the prodromal phase in MS to other immune-mediated diseases
2:42
Increased healthcare use before MS onset as evidence for a potential prodromal phase
VJNeurology
Increased healthcare use before MS onset as evidence for a potential prodromal phase
3:04
The concept of an MS diet: recommendations and lack of evidence
VJNeurology
The concept of an MS diet: recommendations and lack of evidence
4:12
The role of diet in the management of MS
VJNeurology
The role of diet in the management of MS
1:58
A study comparing natalizumab and anti-CD20 antibodies in RRMS in the MENA region
VJNeurology
A study comparing natalizumab and anti-CD20 antibodies in RRMS in the MENA region
4:43
Understanding the complement system in MS pathogenesis and treatment: knowledge gaps
VJNeurology
Understanding the complement system in MS pathogenesis and treatment: knowledge gaps
1:37
A study investigating the association between CCs/CAPs and MS severity and activity
VJNeurology
A study investigating the association between CCs/CAPs and MS severity and activity
4:19
The role of complement activation in the pathogenesis of MS
VJNeurology
The role of complement activation in the pathogenesis of MS
1:53
Advancements in ultra-long-term subcutaneous EEG systems for epilepsy monitoring
VJNeurology
Advancements in ultra-long-term subcutaneous EEG systems for epilepsy monitoring
2:20
A polysomnography study to investigate sleep disturbances in Dravet syndrome
VJNeurology
A polysomnography study to investigate sleep disturbances in Dravet syndrome
4:13
Developing a specialized tool for Dravet disease with associated neuropsychiatric disorder
VJNeurology
Developing a specialized tool for Dravet disease with associated neuropsychiatric disorder
7:26
15-month observational study using subcutaneous EEG to monitor seizures in patients with epilepsy
VJNeurology
15-month observational study using subcutaneous EEG to monitor seizures in patients with epilepsy
5:06
The role of surgery in genetic epilepsies
VJNeurology
The role of surgery in genetic epilepsies
3:20
Plans for implementing a novel clinical prediction model of epilepsy seizure risk into the NHS
VJNeurology
Plans for implementing a novel clinical prediction model of epilepsy seizure risk into the NHS
1:27
Responsive neuromodulation for epilepsy: reducing exposition time to stimulation
VJNeurology
Responsive neuromodulation for epilepsy: reducing exposition time to stimulation
2:41
Developing a clinical prediction model to predict seizure risk in patients with epilepsy
VJNeurology
Developing a clinical prediction model to predict seizure risk in patients with epilepsy
4:28
Evolving trends in pediatric epilepsy surgery & barriers that remain
VJNeurology
Evolving trends in pediatric epilepsy surgery & barriers that remain
4:16
The development of adaptive DBS technology for epilepsy
VJNeurology
The development of adaptive DBS technology for epilepsy
2:03
Long-term sleep recordings to improve sleep disorder diagnostics
VJNeurology
Long-term sleep recordings to improve sleep disorder diagnostics
1:41
Self-applied vs in-lab MSLT: a study for easier narcolepsy diagnosis and investigation
VJNeurology
Self-applied vs in-lab MSLT: a study for easier narcolepsy diagnosis and investigation
3:16
Exploring treatment for CSA: controversies and potential strategies
VJNeurology
Exploring treatment for CSA: controversies and potential strategies
3:07
Understanding the differences in central sleep apnea versus obstructive sleep apnea
VJNeurology
Understanding the differences in central sleep apnea versus obstructive sleep apnea
1:31
The five main symptoms of narcolepsy and cognitive dysfunction
VJNeurology
The five main symptoms of narcolepsy and cognitive dysfunction
2:31
The development of oral orexin receptor 2 agonists for the treatment of narcolepsy type 1
VJNeurology
The development of oral orexin receptor 2 agonists for the treatment of narcolepsy type 1
1:19
Diagnostic tools for phenotyping patients with sleep disorders
VJNeurology
Diagnostic tools for phenotyping patients with sleep disorders
0:50
The challenges of diagnosing hypersomnolence in children
VJNeurology
The challenges of diagnosing hypersomnolence in children
2:46
SUPER-CAT: dual anti-glutamate therapy in super-refractory status epilepticus after cardiac arrest
VJNeurology
SUPER-CAT: dual anti-glutamate therapy in super-refractory status epilepticus after cardiac arrest
8:05
Managing augmentation in RLS: terminating dopaminergic treatment or combining with other agents
VJNeurology
Managing augmentation in RLS: terminating dopaminergic treatment or combining with other agents
1:19
The central role of sleep in the overall health & development of pediatric populations
VJNeurology
The central role of sleep in the overall health & development of pediatric populations
1:43
The evolving understanding of augmentation in RLS: diagnostic criteria and symptomatology
VJNeurology
The evolving understanding of augmentation in RLS: diagnostic criteria and symptomatology
1:39
Collaborative efforts to advance sleep medicine across Europe: the 'Beyond Boundaries' pilot project
VJNeurology
Collaborative efforts to advance sleep medicine across Europe: the 'Beyond Boundaries' pilot project
4:06
Initial treatment of RLS: iron levels, physical activity, & elderly patient care
VJNeurology
Initial treatment of RLS: iron levels, physical activity, & elderly patient care
2:56
Impact of sleep disorders on child development: sleep-disordered breathing, behavior, & academics
VJNeurology
Impact of sleep disorders on child development: sleep-disordered breathing, behavior, & academics
2:13
Wearable devices & deep learning: alternatives to polysomnography for sleep disorder diagnostics
VJNeurology
Wearable devices & deep learning: alternatives to polysomnography for sleep disorder diagnostics
5:02
Dopaminergic agents diminish the response to subsequent non-dopaminergic treatment in RLS
VJNeurology
Dopaminergic agents diminish the response to subsequent non-dopaminergic treatment in RLS
1:49